In this continuation of my last article, we will explore these challenges, the opportunities they present and the future ...

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and bespoke assay services to improve the prediction of in vivo human ...

Dr Diane Proudfoot, Chief Scientific Officer, PlaqueTec “At RxCelerate, we are proud to provide bespoke solutions to our clients to support any or all phases of their drug discovery and ...

Adam Steensberg leads Zealand Pharma, a Danish drug maker whose stock has risen by more than 800 per cent since he took over ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results ...

Antibiotic resistance is a global public health threat. Modern health systems rely on antibiotics to prevent and treat ...

This is the latest in a string of tie-ups by Anglo-Swedish drugmaker AstraZeneca to use artificial intelligence for drug ...

Eradivir $10.25M Series A funding round Two Eradivir employees conduct research on the company’s EV25 influenza therapeutic.

Sixteen patients dosed with Oxbryta® (voxelotor) in a pair of clinical trials have died, European regulators disclosed hours before Pfizer said it was voluntarily withdrawing its sickle cell disease ...

It will be called PHOENICS FLY and get underway as patients in the first phase 3 study are followed in a long-term open-label study. If it makes it to market, the drug could provide a much-needed ...